PPT-PATIENT ACCESS CHALLENGES FACING ABUSE-DETERRENT FORMULATIONS OF OPIOID ANALGESICS
Author : marina-yarberry | Published Date : 2018-11-21
Joshua P Cohen PhD Massachusetts State House February 5 2018 20 of noncancer pain patients are prescribed an opioid compared to lt5 in other industrialized nations
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "PATIENT ACCESS CHALLENGES FACING ABUSE-D..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
PATIENT ACCESS CHALLENGES FACING ABUSE-DETERRENT FORMULATIONS OF OPIOID ANALGESICS: Transcript
Joshua P Cohen PhD Massachusetts State House February 5 2018 20 of noncancer pain patients are prescribed an opioid compared to lt5 in other industrialized nations US has 4 of the worlds population yet 30 of global . Opioid (Narcotic) Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics. Analgesics and Opioids. Analgesics are drugs that relieve pain without causing loss of consciousness.. Opioids are the most effective pain relievers available.. Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None. Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill. He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship. While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972. For this he receive the Meritorious Service Medal. He has practiced adult psychiatry in Grand Junction for 28 years. He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. # . PHL 322, Lab. . 3# . Introduction. - Pain:. an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. - Analgesics :. Prescription opioid abuse and the resurgence of heroin. Opioid Crisis Summit Meeting. October 17, . 2017. Dr. Theodore J. Cicero, PhD. Washington University in St. Louis,. Department of Psychiatry. Email: . Analgesics and Opioids. Analgesics are drugs that relieve pain without causing loss of consciousness.. Opioids are the . most effective pain relievers available.. Terminology. Opioid. . A general term defined as any drug, natural or synthetic, that . Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. FDA’s Role and . Emerging Challenges. Jeanne Ireland. Principal, Ireland Strategies, LLC. 2015 CWAG Annual Meeting. The Opioid Epidemic. Some progress being made, but devastating effects of epidemic continue. Effectiveness and Value. Presentation to the Massachusetts Drug Formulary Commission. February 5, 2018. Presentation Agenda. Introduction to ICER. Comparative clinical effectiveness of abuse-deterrent formulations of opioids (ADFs). Ernest J Dole, PharmD, . PhC. , FASHP, BCPS. Clinical Pharmacist & . Asso. . Clinical Prof.. University of New Mexico Hospitals & College of Pharmacy. Albuquerque, NM. Learning Objectives. At the end of this presentation, utilizing a case of an older patient on chronic opioid therapy (COT) with the comorbidity of geriatric opioid abuse (GOA) the participant will be able to. 3# . Introduction. - Pain:. an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. - Analgesics :. Drugs used to relief or suppress the pain.. . . Kumari. . Anjana. Assistant Professor. Deptt. . of Veterinary Pharmacology & Toxicology. Bihar Veterinary College, Bihar Animal Sciences University, Patna. Opioid analgesics. Are the drugs that significantly relieve pain by acting in central nervous system or on peripheral mechanisms without affecting consciousness.. Narcotic. analgesics). Pain . is . . an unpleasant sensation that can be either . acute or chronic . and is a consequence of . neurochemical . processes in the peripheral . and . (CNS). . treatment .
Download Document
Here is the link to download the presentation.
"PATIENT ACCESS CHALLENGES FACING ABUSE-DETERRENT FORMULATIONS OF OPIOID ANALGESICS"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents